Li Y, Hao J, Jiang Y-M, Liu Y, Zhang S-H
Department of Gynecology, Weihai Municipal Hospital, Weihai, China.
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):10915. doi: 10.26355/eurrev_202011_23548.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long non-coding RNA DSCAM-AS1 indicates a poor prognosis and modulates cell proliferation, migration and invasion in ovarian cancer via upregulating SOX4, by Y. Li, J. Hao, Y.-M. Jiang, Y. Liu, S.-H. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (10): 4143-4148-DOI: 10.26355/eurrev_201905_17916-PMID: 31173284" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17916.
由于本文涉嫌研究不当行为，且通讯作者未回应我们关于证明数据和图表原创性的要求，“Y. Li、J. Hao、Y.-M. Jiang、Y. Liu、S.-H. Zhang发表于《欧洲医学与药理学评论》2019年；23(10):4143 - 4148 - DOI: 10.26355/eurrev_201905_17916 - PMID: 31173284的‘长链非编码RNA DSCAM - AS1预示卵巢癌预后不良并通过上调SOX4调节细胞增殖、迁移和侵袭’”已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/17916 。
